ICUI (STOCKS)
ICU Medical Inc
$183.110000
+3.770000 (+2.10%)
Prev close: $179.340000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Vivek Jain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,743.31M
- Employees
- 15,000
- P/E (TTM)
- 151.50
- P/B (TTM)
- 2.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$2.37 | $1.95 | +0.4182 | +21.43% |
|
Mar 2026 (Q1)
|
$1.97 | $1.79 | +0.1833 | +10.26% |
|
Dec 2025 (Q4)
|
$1.91 | $1.73 | +0.1843 | +10.68% |
|
Sep 2025 (Q3)
|
$2.03 | $1.46 | +0.5680 | +38.85% |
Financial Statements
| Revenues | $2.16B |
| Benefits Costs and Expenses | $2.16B |
| Cost Of Revenue | $1.31B |
| Costs And Expenses | $2.16B |
| Gross Profit | $845.15M |
| Nonoperating Income/Loss | -$1.58M |
| Operating Expenses | $773.09M |
| Selling, General, and Administrative Expenses | $615.07M |
| Research and Development | $86.32M |
| Other Operating Expenses | $71.69M |
| Operating Income/Loss | $72.06M |
| Income/Loss Before Equity Method Investments | $1.19M |
| Income/Loss From Continuing Operations After Tax | $31.10M |
| Income/Loss From Continuing Operations Before Tax | $754.00K |
| Income/Loss From Equity Method Investments | -$1.62M |
| Income Tax Expense/Benefit | -$30.96M |
| Interest Expense, Operating | $83.00M |
| Net Income/Loss | $30.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $30.09M |
| Net Income/Loss Available To Common Stockholders, Basic | $30.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.20 |
| Diluted Earnings Per Share | $1.19 |
| Basic Average Shares | 74,466,000 |
| Diluted Average Shares | 75,033,000 |
| Assets | $3.97B |
| Current Assets | $1.21B |
| Inventory | $607.42M |
| Other Current Assets | $603.49M |
| Noncurrent Assets | $2.76B |
| Fixed Assets | $446.80M |
| Intangible Assets | $567.67M |
| Other Non-current Assets | $1.75B |
| Liabilities | $1.82B |
| Current Liabilities | $498.36M |
| Accounts Payable | $149.17M |
| Other Current Liabilities | $349.20M |
| Noncurrent Liabilities | $1.32B |
| Equity | $2.15B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.15B |
| Liabilities And Equity | $3.97B |
| Net Cash Flow From Operating Activities | $236.37M |
| Net Cash Flow From Operating Activities, Continuing | $236.37M |
| Net Cash Flow From Investing Activities | -$79.77M |
| Net Cash Flow From Investing Activities, Continuing | -$79.77M |
| Net Cash Flow From Financing Activities | -$154.53M |
| Net Cash Flow From Financing Activities, Continuing | -$154.53M |
| Exchange Gains/Losses | -$3.80M |
| Net Cash Flow | -$1.73M |
| Net Cash Flow, Continuing | $2.07M |
| Comprehensive Income/Loss | $19.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $19.40M |
| Other Comprehensive Income/Loss | -$10.69M |